OncLive
Andrew Kin, M.D., hematologist, medical oncologist, and member of the Hematology Oncology, Multiple Myeloma and Amyloidosis and Bone Marrow & Stem Cell Transplant Multidisciplinary Teams at Karmanos, talks to OncLive TV about the recent U.S. Food and Drug Administration approval for teclistamab and its uses for relapsed/refractory multiple myeloma.
Watch here.